APMTD specializes in designing and developing minimally invasive device solutions for unmet medical needs such as stroke, heart failure, eCPR and peripheral vascular diseases. The company's local drug delivery system TAPAS and targeted hypothermia induction system DuoFlo have been approved for commercialization in US, China, EU, Australia and Taiwan region.